Fiche centre
Clinical Associates of Orlando, LLC
Orlando — United States
Essais liés3clinical trials
VilleOrlandolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07816367
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Elismetrep | Migraine | Phase 3 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | NOT_YET_RECRUITING |
| Rimegepant (PF-07899801) | Migraine | Phase 3 | NCT04743141 | Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine | RECRUITING |
| Rimegepant/BHV3000 | Migraine | Phase 3 | NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | RECRUITING |